Impact of <i>Clostridioides difficile</i> Therapy on Nosocomial Acquisition of Vancomycin-Resistant Enterococci
Vancomycin is frequently used for the treatment of <i>C. difficile</i> infections (CDI). There are concerns that this might increase the risk of selecting vancomycin resistant enterococci (VRE). Here, we evaluated whether there is an increased risk of VRE acquisition following vancomycin...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
MDPI AG
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/19921aa1bb474ee3adf18d88cd120d7b |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|